Structure Therapeutics (GPCR) PT Lowered to $110 at Citizens

August 7, 2026 7:26 AM

Citizens analyst Jonathan Wolleben lowered the price target on Structure Therapeutics (NASDAQ: GPCR) to $110.00 (from $113.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found